Clinical trial
Single-stage Pulmonary Vein Isolation Combined With Percutaneous Left Atrial Appendage Occluder Implantation in Patients With Recent Onset Ischemic Stroke and Atrial Fibrillation (PILOS-AF)
NCT06212674 is registered in ClinicalTrials.gov with Medical University of Silesia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single-stage Pulmonary Vein Isolation Combined With Percutaneous Left Atrial Appendage Occluder Implantation in Patients With Recent Onset Ischemic Stroke and Atrial Fibrillation (PILOS-AF)
- Lead sponsor
- Medical University of Silesia
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- October 31, 2025
- Completion date
- October 31, 2030
- Enrollment
- 240 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.